Total Valuation
StemGen has a market cap or net worth of $4.57K. The enterprise value is $5.13M.
Market Cap$4.57K
Enterprise Value$5.13M
Share Statistics
StemGen has 45,671,062 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding45,671,062
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
StemGen’s return on equity (ROE) is 0.32 and return on invested capital (ROIC) is 31.65%.
Return on Equity (ROE)0.32
Return on Assets (ROA)-1.08
Return on Invested Capital (ROIC)31.65%
Return on Capital Employed (ROCE)0.18
Revenue Per Employee39.00K
Profits Per Employee-433.14K
Employee Count1
Asset Turnover0.10
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of StemGen is ―. StemGen’s PEG ratio is -6.64.
PE Ratio―
PS Ratio1169.23
PB Ratio-34.18
Price to Fair Value-34.18
Price to FCF-322.96
Price to Operating Cash Flow-32.30
PEG Ratio-6.64
Income Statement
In the last 12 months, StemGen had revenue of 39.00K and earned -433.00K in profits. Earnings per share was -0.01.
Revenue39.00K
Gross Profit8.55K
Operating Income-244.00K
Pretax Income-433.00K
Net Income-433.00K
EBITDA-179.87K
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -259.74K and capital expenditures 0.00, giving a free cash flow of -259.74K billion.
Operating Cash Flow-259.74K
Free Cash Flow-259.74K
Free Cash Flow per Share>-0.01
Dividends & Yields
StemGen pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.00
52-Week Price Change0.00%
50-Day Moving Average0.10
200-Day Moving Average0.10
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
StemGen upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
StemGen as a current ratio of <0.01, with Debt / Equity ratio of -42.22%
Current Ratio<0.01
Quick Ratio<0.01
Debt to Market Cap0.01
Net Debt to EBITDA-3.12
Interest Coverage Ratio-1.73
Taxes
In the past 12 months, StemGen has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
StemGen EV to EBITDA ratio is -256.65, with an EV/FCF ratio of -326.93.
EV to Sales1.18K
EV to EBITDA-256.65
EV to Free Cash Flow-326.93
EV to Operating Cash Flow-326.93
Balance Sheet
StemGen has $22.87K in cash and marketable securities with $563.20K in debt, giving a net cash position of -$540.33K billion.
Cash & Marketable Securities$22.87K
Total Debt$563.20K
Net Cash-$540.33K
Net Cash Per Share-$0.01
Tangible Book Value Per Share-$0.03
Margins
Gross margin is 21.91%, with operating margin of -625.64%, and net profit margin of -1110.26%.
Gross Margin21.91%
Operating Margin-625.64%
Pretax Margin-1110.26%
Net Profit Margin-1110.26%
EBITDA Margin-461.19%
EBIT Margin-748.72%
Analyst Forecast
The average price target for StemGen is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―